Interleukin-6 as a potential biomarker of COVID-19 progression
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“[5] Zhou F, Yu T, Du R, Fan 4, Liu Y, Liu Z, et al.”
BackgroundDysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · cited 1×
“[9] Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al.”
BackgroundDiagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Chen, X., Zhao, B., Qu, Y., Chen, Y., Xiong, J., Feng, Y., Men, D., Huang, Q., Liu, Y., Yang, B., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa449 · Cited by 1,020
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,ChinaPreprint
Liu, L., Gao, J.-Y., Hu, W.-M., Zhang, X.-X., Guo, L., Liu, C.-Q., Tang, Y.-W., Lang, C., Mou, F., Yi, Z.-J., et al. (2020) · medRxiv · doi:10.1101/2020.02.20.20025536 · Cited by 103
Wu, C., Hu, X., Song, J., Du, C., Xu, J., Yang, D., Chen, D., Zhong, M., Jiang, J., Xiong, W., et al. (2020) · medRxiv · doi:10.1101/2020.02.26.20028589 · Cited by 95
Yang, P., Ding, Y., Xu, Z., Pu, R., Li, P., Jin, Y., Liu, J., Meng, F., Huang, L., Shi, L., et al. (2020) · medRxiv · doi:10.1101/2020.02.28.20028068 · Cited by 91
Liu, J., Ouyang, L., Guo, P., Wu, H., Fu, P., Chen, Y., Yang, D., Han, X., Cao, Y., Alwalid, O., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.54257 · Cited by 70
Involvement of Interleukin 6 in Hepatitis B Viral Infection
Xia, C., Liu, Y., Chen, Z., & Zheng, M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430386 · Cited by 67
Cited by
Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.003 · Cited by 1,288
“high serum IL-6 levels were suggested as predictors for disease severity [27,28].”
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102573 · Cited by 268
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients
Valizadeh, H., Abdolmohammadi-vahid, S., Danshina, S., Ziya Gencer, M., Ammari, A., Sadeghi, A., Roshangar, L., Aslani, S., Esmaeilzadeh, A., Ghaebi, M., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107088 · Cited by 267
Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A., & Kennedy, R. B. (2020) · Immunological Reviews · doi:10.1111/imr.12897 · Cited by 258
Lymphocyte Subset Counts in COVID‐19 Patients: A Meta‐Analysis
Huang, W., Berube, J., McNamara, M., Saksena, S., Hartman, M., Arshad, T., Bornheimer, S. J., & O'Gorman, M. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24172 · Cited by 237
“Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.”
BackgroundControlling Cytokine Storm Is Vital in COVID-19
Tang, L., Yin, Z., Hu, Y., & Mei, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570993 · Cited by 183
“9-fold higher levels in patients with complicated COVID-19 compared with those with non-complicated disease (74), and another meta-analysis also reported the relation between IL-6 levels and severe condition (75), indicating that IL-6 was a good indicator of poor prognosis in COVID-19 (74).”
BackgroundSabaka, P., Koščálová, A., Straka, I., Hodosy, J., Lipták, R., Kmotorková, B., Kachlíková, M., & Kušnírová, A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05945-8 · Cited by 130
Bektas, A., Schurman, S. H., Franceschi, C., & Ferrucci, L. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00196-8 · Cited by 102
Cellular senescence as a potential mediator of COVID‐19 severity in the elderly
Nehme, J., Borghesan, M., Mackedenski, S., Bird, T. G., & Demaria, M. (2020) · Aging Cell · doi:10.1111/acel.13237 · Cited by 94
The hormetic and hermetic role of IL-6
Forcina, L., Franceschi, C., & Musarò, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101697 · Cited by 85
“Furthermore, the extent of IL-6 elevation has been also proposed as a marker of disease progression and a prognosis predictor in infected patients (Gubernatorova et al., 2020; Ulhaq and Soraya, 2020).”
COVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
“Elevated serum 613 levels of IL-6 are a reliable predictor of respiratory 614 dysfunction in COVID-19 [75, 152].”
BackgroundMolecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus
Parczewski, M., & Ciechanowicz, A. (2020) · Polish Archives of Internal Medicine · doi:10.20452/pamw.15550 · Cited by 17
“including interleukin 1 (IL-1), 6 (IL-6) or tumor necrosis factor (TNF α) levels reflect the cytokine release storm and may be a predictor of disease severity [25].”
Background
Metadata
- Authors
- Ulhaq, Z. S., & Soraya, G. V.
- Venue
- Médecine et Maladies Infectieuses
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 50
- Issue
- 4
- Pages
- 382-383
- ISSN
- 0399-077X (ISSN-L)
- OpenAlex
- W3014130682
- Cited by
- 331
- References
- 10
- FWCI
- 9.17
- Type
- journal article
- Language
- fr
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.